A well-formulated ketogenic diet—very low in carbohydrates and high in fats—typically produces a characteristic lipid response: lower triglycerides, higher HDL cholesterol, and variable changes in LDL cholesterol. Jeff S. Volek at The Ohio State University has described this pattern in clinical studies of carbohydrate-restricted diets, and Katherine Zeratsky at Mayo Clinic emphasizes the same trade-offs in patient-facing guidance. These changes arise from altered metabolic pathways and from the types of fats consumed.
Mechanisms and causes
Shifting metabolism from carbohydrate to fat oxidation reduces hepatic production of triglyceride-rich very low-density lipoprotein, which commonly lowers circulating triglycerides and contributes to increases in HDL. David S. Ludwig at Harvard Medical School explains that lowering insulin and carbohydrate load changes liver handling of lipids and lipoprotein assembly, accounting for these consistent effects. Conversely, the effect on LDL varies: when a ketogenic eating pattern increases intake of saturated fat—more common with diets built around butter, fatty meats, and high-fat dairy—LDL cholesterol often rises because saturated fat can reduce hepatic LDL receptor activity and raise circulating LDL particles. Some people are “hyper-responders,” showing large LDL increases on a high-fat, low-carb plan while others see little change or even modest decreases.
Weight loss itself also modifies lipids. Rapid fat mobilization during calorie restriction can transiently increase LDL as stored cholesterol is released, even as triglycerides fall. Food quality matters: replacing saturated fats with unsaturated vegetable oils tends to blunt LDL rises while preserving improvements in triglycerides and HDL.
Consequences and clinical assessment
Elevations in LDL cholesterol are clinically important because LDL-containing particles drive atherosclerotic risk; changes in overall cardiovascular risk depend on the balance of lipid effects and on measures of particle number such as apoB or LDL particle concentration. Many clinicians therefore monitor apoB or advanced lipid testing when a patient adopts a ketogenic diet to distinguish an increase in larger, less atherogenic LDL particles from an increase in total particle number. Jeff S. Volek at The Ohio State University and other lipid researchers recommend individualized assessment: if LDL or apoB rises substantially, clinicians often advise shifting fat sources toward unsaturated fats, increasing dietary fiber and plants, or considering pharmacologic therapy.
Cultural and environmental context influences both risk and feasibility. In regions where high-quality plant fats and seafood are less available or expensive, ketogenic patterns may rely on more animal-sourced saturated fats, increasing the likelihood of LDL rises and producing a larger ecological footprint. Individual genetics, underlying metabolic health, and local food systems all shape the net cardiovascular effect.
Patients and clinicians should track fasting lipid panels after dietary changes, discuss results in context, and weigh benefits such as improved triglycerides and glycemic markers against potential LDL-related atherosclerotic risk.